AFMD
Price
$0.81
Change
+$0.04 (+5.19%)
Updated
Apr 24, 02:10 PM (EDT)
Capitalization
12.11M
27 days until earnings call
LRMR
Price
$2.27
Change
+$0.02 (+0.88%)
Updated
Apr 24, 02:36 PM (EDT)
Capitalization
152.39M
14 days until earnings call
Ad is loading...

AFMD vs LRMR

Header iconAFMD vs LRMR Comparison
Open Charts AFMD vs LRMRBanner chart's image
Affimed
Price$0.81
Change+$0.04 (+5.19%)
Volume$754
Capitalization12.11M
Larimar Therapeutics
Price$2.27
Change+$0.02 (+0.88%)
Volume$106
Capitalization152.39M
AFMD vs LRMR Comparison Chart
Loading...
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AFMD vs. LRMR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFMD is a Buy and LRMR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (AFMD: $0.77 vs. LRMR: $2.26)
Brand notoriety: AFMD and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AFMD: 96% vs. LRMR: 163%
Market capitalization -- AFMD: $12.11M vs. LRMR: $152.39M
AFMD [@Biotechnology] is valued at $12.11M. LRMR’s [@Biotechnology] market capitalization is $152.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AFMD’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • AFMD’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than AFMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AFMD’s TA Score shows that 6 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • AFMD’s TA Score: 6 bullish, 2 bearish.
  • LRMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AFMD is a better buy in the short-term than LRMR.

Price Growth

AFMD (@Biotechnology) experienced а +6.10% price change this week, while LRMR (@Biotechnology) price change was +22.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

AFMD is expected to report earnings on Aug 07, 2025.

LRMR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($152M) has a higher market cap than AFMD($12.1M). AFMD YTD gains are higher at: -35.269 vs. LRMR (-41.602). AFMD has higher annual earnings (EBITDA): -65.19M vs. LRMR (-73.44M). LRMR has more cash in the bank: 204M vs. AFMD (24.9M). LRMR has less debt than AFMD: LRMR (5.36M) vs AFMD (12.9M). AFMD has higher revenues than LRMR: AFMD (877K) vs LRMR (0).
AFMDLRMRAFMD / LRMR
Capitalization12.1M152M8%
EBITDA-65.19M-73.44M89%
Gain YTD-35.269-41.60285%
P/E RatioN/AN/A-
Revenue877K0-
Total Cash24.9M204M12%
Total Debt12.9M5.36M241%
FUNDAMENTALS RATINGS
AFMD vs LRMR: Fundamental Ratings
AFMD
LRMR
OUTLOOK RATING
1..100
1722
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
9490
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
4n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (19) in the null industry is somewhat better than the same rating for AFMD (70) in the Biotechnology industry. This means that LRMR’s stock grew somewhat faster than AFMD’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as AFMD (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to AFMD’s over the last 12 months.

AFMD's SMR Rating (96) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that AFMD’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (90) in the null industry is in the same range as AFMD (94) in the Biotechnology industry. This means that LRMR’s stock grew similarly to AFMD’s over the last 12 months.

AFMD's P/E Growth Rating (95) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that AFMD’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AFMDLRMR
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
AFMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INMB8.250.41
+5.23%
INmune Bio
LH224.143.89
+1.77%
Laboratory Corp
HASI24.350.06
+0.25%
HA Sustainable Infrastructure Capital Inc.
CECO18.71-0.06
-0.32%
CECO Environmental Corp
AEI0.92-0.03
-2.72%
Alset

AFMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, AFMD has been loosely correlated with GPCR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AFMD jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AFMD
1D Price
Change %
AFMD100%
+4.24%
GPCR - AFMD
45%
Loosely correlated
+1.22%
BYSI - AFMD
40%
Loosely correlated
+10.29%
NTLA - AFMD
37%
Loosely correlated
-2.65%
LRMR - AFMD
35%
Loosely correlated
-5.04%
CRSP - AFMD
34%
Loosely correlated
-1.76%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with SVRA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then SVRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-5.04%
SVRA - LRMR
46%
Loosely correlated
+0.93%
ERAS - LRMR
46%
Loosely correlated
+2.90%
PRME - LRMR
45%
Loosely correlated
+4.14%
ACLX - LRMR
45%
Loosely correlated
+0.81%
IMNM - LRMR
44%
Loosely correlated
+3.54%
More